MAPT and Alzheimer disease: That is, TI is a measure of tau burden, focusing on regions that develop tau pathology early in the disease for an amnestic AD cohort, while TSS is a measure of tau spread, including all cortical regions without regard to how much tau pathology continues to develop in impacted regions.